Ekso Bionics Holdings
Stock Forecast, Prediction & Price Target
Ekso Bionics Holdings Financial Estimates
Ekso Bionics Holdings Revenue Estimates
Ekso Bionics Holdings EBITDA Estimates
Ekso Bionics Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $11.24M N/A | $12.91M 14.81% | $18.27M 41.56% | Avg: $28.10M Low: $27.72M High: $28.48M avg. 53.75% | Avg: $35.56M Low: $35.09M High: $36.04M avg. 26.56% | Avg: $45.21M Low: $44.61M High: $45.82M avg. 27.11% | Avg: $56.95M Low: $56.19M High: $57.72M avg. 25.96% |
Net Income
% change YoY
| $-8.43M N/A | $-14.60M -73.19% | $-15.19M -4.06% | Avg: $-4.89M Low: $-4.02M High: $-2.63M avg. 67.81% | Avg: $287K Low: $136.25K High: $141.09K avg. 105.86% | Avg: $3.18M Low: $3.13M High: $3.24M avg. 1011.29% | Avg: $6.79M Low: $6.67M High: $6.91M avg. 113.04% |
EBITDA
% change YoY
| $-14.71M N/A | $-15.58M -5.94% | $-13.19M 15.32% | Avg: $-26.60M Low: $-26.96M High: $-26.25M avg. -101.60% | Avg: $-33.67M Low: $-34.12M High: $-33.22M avg. -26.56% | Avg: $-42.80M Low: $-43.38M High: $-42.23M avg. -27.11% | Avg: $-53.92M Low: $-54.65M High: $-53.20M avg. -25.96% |
EPS
% change YoY
| -$0.69 N/A | -$1.13 -63.76% | -$1.1 2.65% | Avg: -$0.24 Low: -$0.29 High: -$0.19 avg. 78.18% | Avg: $0.01 Low: $0.01 High: $0.01 avg. 104.16% | Avg: $0.23 Low: $0.23 High: $0.23 avg. 2200% | Avg: $0.49 Low: $0.48 High: $0.5 avg. 113.04% |
Operating Expenses
% change YoY
| $20.57M N/A | $21.77M 5.79% | $24.19M 11.12% | Avg: $40.07M Low: $39.54M High: $40.61M avg. 65.67% | Avg: $50.72M Low: $50.04M High: $51.40M avg. 26.56% | Avg: $64.48M Low: $63.61M High: $65.34M avg. 27.11% | Avg: $81.22M Low: $80.13M High: $82.31M avg. 25.96% |
FAQ
What is Ekso Bionics Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 324.50% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -4.02M, average is -4.89M and high is -2.63M.
What is Ekso Bionics Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 33.34% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $27.72M, average is $28.10M and high is $28.48M.
What is Ekso Bionics Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 623.84% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.29, average is -$0.24 and high is $-0.19.
What is the best performing analyst?
In the last twelve months analysts have been covering Ekso Bionics Holdings stock. The most successful analyst is Ben Haynor.